Nigeria: COVID-19 - Nigeria Won't Suspend Hydroxychloroquine Trial - NAFDAC

The Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) building.

Barely 24 hours after the World Health Organisation (WHO) suspended all clinical trials for hydroxychloroquine as a potential treatment for COVID-19, the National Agency for Food and Drug Administration and Control (NAFDAC) has said the trial will continue in Nigeria.

The Director-General of the agency, Mojisola Adeyeye, made this known during an interview on Television Continental (TVC) on Tuesday.

The UN agency had on Monday said it had 'temporarily' suspended the clinical trials of hydroxychloroquine as a potential treatment for COVID-19 over safety concerns.

It said the decision followed a study in The Lancet that the use of the drug on COVID-19 patients could increase their likelihood of dying.

"The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board, " WHO Director-General, Tedros Ghebreyesus said.

Chloroquine is a synthetic drug introduced in the 1940s. It is a member of an important series of chemically related agents known as quinoline derivatives. Hydroxychloroquine is a related compound that was introduced in 1955.

Clinical trials in Nigeria

Mrs Adeyeye, however, said there are proven records that hydroxychloroquine has been effective in the treatment of COVID-19 patients.

This she said is most effective in those at the mild stage of the virus.

"There is data to prove that hydroxychloroquine worked for many COVID-19 patients.

"Therefore, we would continue our own clinical trials in Nigeria.

"Hydroxychloroquine has been proved to work at a mild stage. So the potency depends on the severity of the disease in the patient's body," she said.

Treating COVID-19 with Chloroquine

There has been controversy trailing the use of chloroquine to treat COVID-19 patients.

U.S. President Donald Trump last week said he had been using hydroxychloroquine to protect himself against COVID-19.

However, Nigeria's Presidential Task Force (PTF) on coronavirus at a daily briefing warned Nigerians against using the drug.

It said the drug has not been declared a cure for the disease and further warned of the possibility of chloroquine poisoning if one indulges in self-medication with the drug.

Bauchi State governor, Bala Mohammed, who was the index case of COVID-19 in his state, had told journalists early this month that he was treated with chloroquine, zithromax, and vitamin c during his successful treatment for the disease.

The governor said COVID-19 patients in the state would, henceforth, be treated with the drugs.

AllAfrica publishes around 700 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.